Andreas Hohn Email & Phone Number

Basel

Andreas is currently in a senior negotiator role for partnerships with biotech and pharma companies. Deals span all therapeutic areas and many technology platforms worldwide. He has established 40 licensing agreements since 2014.

Basel

Responsible globally for business development in biologics and biomarkers. Established 13 partnerships and 1 acquisition. Therapeutic areas: Oncology, Neuroscience, Ophthalmology, Inflammation and Infectious Diseases.

Basel

Basel

Andreas worked as a business developer at the Novartis Institutes for Biomedical Research (NIBR). He was responsible for Neuroscience and Musculoskeletal diseases as well as technologies in Lead Identification/Lead Optimization.

Basel

Andreas joined the start-up, bioinformatics company as the 7th employee and helped to grow the company to 60 employees. He established the first partnerships by himself and then grew the sales, business development and marketing department.

Basel, Switzerland

Developed toxicogenomics as a key business area. Established Genedata as the principal bioinformatics partner within InnoMed, a major pharma-driven EU consortium for drug safety prediction based on omics data. Involved in three toxicogenomics consortia funded by the EU and including SMEs, hospitals, academia and large life science organizations (e.g..

Basel, Switzerland

Built business relations across Europe. Hired and integrated 11 sales, marketing and business development personnel. Established software and consulting business with 8 major pharma and crop science companies. Developed and implemented marketing strategies. Prepared business/scientific presentations and publications in genomics and bioinformatics journals..

Tübingen, Germany

Andreas was a research group leader at the Department of Biochemistry (head: Prof. U. Schwarz). He worked on neocortical development and lead a team of 4 students, postdocs and technicians.